tiprankstipranks

Alfred Altomari Insider Profile

4 Followers
Alfred Altomari, CEO, Director at Agile Therapeutics, holds 69.50K shares in Insmed (Ticker: INSM), holds 47.75K shares in Agile Therapeutics (Ticker: AGRX), holds 117.78K shares in Baudax Bio (Ticker: BXRXQ).
tipranks
Alfred Altomari

Alfred Altomari
Agile Therapeutics (AGRX)
CEO, Director

Ranked #94,636 out of 99,541 Corporate Insiders

Profitable Transactions

32%
6 out of 19 Profitable Transactions

Average Return

-29.70%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$4M
99.59%
0.38%
0.03%
A breakdown of Alfred Altomari's holdings

Insider Roles

Insmed
(INSM)
Director
Agile Therapeutics
(AGRX)
CEO, Director
Baudax Bio
(BXRXQ)
Director
Roles that Alfred Altomari holds in companies

Most Profitable Insider Trade

Stock:
Agile Therapeutics
(AGRX)
Rating:Informative Buy
Date:Jun 11, 2019 - Jun 11, 2020
Return:+101.50%
The most profitable trade made by Alfred Altomari

Alfred Altomari's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Agile Therapeutics
Jun 30, 2023
CEO, Director
Uninformative Buy
$16.90K
Baudax Bio
Apr 08, 2021
Director
Uninformative Buy
$1.18K
Insmed
May 15, 2024
Director
Uninformative Buy
$4.44M
SCTL
Societal CDMO
Dec 09, 2019
Uninformative Buy
$48.62K
AUXL
Auxilium
List of latest transactions for each holding click on a transaction to see Alfred Altomari's performance on stock

Alfred Altomari insider profile FAQ

What is the percentage of profitable transactions made by Alfred Altomari?
The percentage of profitable transactions made by Alfred Altomari is 32%.
    What is the average return per transaction made by Alfred Altomari?
    The average return per transaction made by Alfred Altomari is -29.70%.
      What stocks does Alfred Altomari hold?
      Alfred Altomari holds: AGRX, BXRXQ, INSM, SCTL, AUXL stocks.
        What was Alfred Altomari’s latest transaction?
        Alfred Altomari latest transaction was an Uninformative Buy of ―.
          What was Alfred Altomari's most profitable transaction?
          Alfred Altomari’s most profitable transaction was an Informative Buy of AGRX stock on June 11, 2019. The return on the trade was 101.50%.
            What is Alfred Altomari's role in Agile Therapeutics?
            Alfred Altomari's role in Agile Therapeutics is CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.